Drug Research
Centivax partners with US NMRC to study Covid-19 antibody
Centivax has signed a strategic collaboration with the US Naval Medical Research Center (NMRC) to conduct Phase I clinical development of its SARS-CoV-2 antibody, Centi-B9.
Centi-B9 is designed as a broad-spectrum therapeutic and prophylactic for administration through injections. It is...
News
UK approves Johnson & Johnson’s single-dose Covid vaccine for use
The U.K.’s medicines regulator on Friday approved Janssen’s single-dose Covid-19 vaccine for use. Britain’s Medicines and Healthcare products Regulatory Agency said that doses were expected to be available in the U.K. later this year.
The British government’s Vaccine Taskforce has...
News
‘Black Mould’ [Mucormycosis] – the Dark Side of At-home and Self-COVID-19 Treatment
In fact, it’s not just this particular bug that we need to be concerned about. There are other cousins of mucor lurking in our environment, waiting for the perfect storm of a host to take residence in. Ever wonder...
News
‘COVIDASHA’, a technology shot to battle the 2nd wave of the pandemic
CovidAsha, a chatbot platform on the Web, WhatsApp and Telegram, is a unique initiative by conversational automation heavy-weights Engati, and healthcare ecosystem players like Pharmeasy, VMedo, StanPlus and The Better India, with WhatsApp providing the platform.
CovidAsha was born out...
News
Onyx Scientific bolsters manufacturing capabilities with commercial API license
Onyx Scientific, a small molecule API contract development and manufacturing organisation has received a commercial API license for its UK facility.
The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from...
News
Global exclusive as Iceni Diagnostics licences key virus detection IP from University of Warwick
Iceni Diagnostics, a specialist carbohydrate chemistry company based in Norwich, is delighted to announce that it has agreed an exclusive global licence, to integrate key virus detection intellectual property (IP) developed by the University of Warwick, into its commercial...
News
India’s Drug Regulator DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines
India’s top drug regulator exempted foreign-made COVD-19 vaccines from post-approval bridging trials in the country, if they are approved by certain health bodies.
According to the Indian Express, companies such as Pfizer and Cipla have asked for these exemptions during...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read